Patients to suffer from PBS windfall

Government moves to curb pharmaceutical spending have already reaped a massive savings windfall, say health interest groups who are concerned further budget cuts will impact patient outcomes.

The latest PBS Scorecard, released today by the Medicines Partnership of Australia, reveals the PBS will cost $4.5 billion less from 2013-14 to 2016-17 than was forecast in last years budget.

The vast majority of this ($3.8 billion) comes from existing reforms and lower than expected growth, while the remaining $0.7 billion comes from co-payment increases and safety net